The Solubility Company and Persist AI Unveil Strategic Partnership to Enable Microgram-Level Formulation Development and Bridge the Data Gap in AI-Driven Drug Formulation
Summary
Persist AI and The Solubility Company announced a strategic collaboration to launch the first fully automated SPA® (single particle analysis) platform integrated into Persist AI's AI-driven Cloud Lab. The integration pairs ultra-low-sample solubility measurement with high-throughput robotics and predictive AI to generate high-fidelity preclinical formulation data from as little as one milligram. The companies will co-develop non‑proprietary datasets and predictive models to accelerate formulation decisions, cut repetitive downstream wet-lab work, and fast-track promising assets toward IND readiness. The partnership addresses physical-chemistry data scarcity and offers automated SPA® capabilities to cloud lab customers and pilot partners to accelerate preclinical formulation workflows.